Abstract
Human leukocyte antigens (HLA) class I molecules restrict the interaction between cytotoxic T cells and target cells. Abnormalities in HLA class I antigen expression and/or function may provide tumor cells with a mechanism for escaping immune surveillance and resisting T cell-based immunotherapies. The potential for applying T cell-based immunotherapy in the treatment of acute myeloid leukemia (AML) has stimulated interest in analyzing HLA class I antigen expression on leukemic blasts in this disease. Little information is available in the literature. We have analyzed HLA class I antigen expression on bone marrow samples from 25 newly diagnosed AML patients by indirect immunofluorescence staining with monoclonal antibodies. Five of these patients were also studied at relapse. Leukemic blasts were resolved from normal lymphocytes by staining with anti-CD45 antibody; CD45 expression is dim on leukemia cells, but bright on lymphocytes. HLA class I antigen expression was higher on leukemic blasts than on autologous lymphocytes in all but one case. Moreover, there was no significant change in HLA class I antigen expression at relapse. These results suggest that abnormalities in HLA class I antigens are infrequent in AML and should not represent a major obstacle to the application of T cell-based immunotherapies in this disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ferrone S, Marincola FM . Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance Immunol Today 1995 16: 487–494
D'Alfonso S, Savoia P, Pitti G, Peruccio D, Pozzi C, Crepaldi T, Falda M, Ficara F, Resegotti L, Momigliano Richiardi P . Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells Eur J Immunogenet 1993 20: 165–173
Savoia P, D'Alfonso S, Peruccio D, Isabella N, Falda M, Rasegotti L, Richiardi P . Loss of surface HLA class I molecules in leukemic myeloblasts is correlated with an increased leukocyte concentration at onset Haematologica 1992 77: 127–129
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 620–625
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol 1991 78: 325–329
Mitelman F (ed) . ISCN: An International System for Human Cytogenetic Nomenclature Karger: Basel 1995
Wetzler M, Baer MR, Bernstein SH, Blumenson L, Stewart C, Barcos M, Mrozek K, Block AW, Herzig GP, Bloomfield CD . Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy J Clin Oncol 1997 15: 2262–2268
Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, Sawitsky A, Stass S, Weinstein H, Woods WG . Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia J Clin Oncol 1990 8: 813–819
Desai SA, Wang X, Noronha EJ, Zhou Q, Rebmann V, Grosse-Wilde H, Moy FJ, Powers R, Ferrone S . Structural relatedness of distinct determinants recognized by mAb TP25.99 on b2-m associated and b2-m free HLA class I heavy chains J Immunol 2000 165: 3275–3283
Yang SY, Morishima Y, Collins NH, Alton T, Pollack MS, Yunis EJ, Dupont B . Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes Immunogenetics 1984 19: 217–231
Tsujisaki M, Sakaguchi K, Igarashi M, Richiardi P, Perosa F, Ferrone S . Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1 Transplantation 1988 45: 632–639
Sakaguchi K, Ono R, Tsujisaki M, Richiardi P, Carbonara A, Park MS, Tonai R, Terasaki PI, Ferrone S . Anti-HLA-B7, B27, Bw42, Bw54, Bw55, Bw56, Bw67, Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay Hum Immunol 1988 21: 193–207
Pellegrino MA, Ng AK, Russo C, Ferrone S . Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules Transplantation 1982 34: 18–23
Stewart CC . Clinical applications of flow cytometry: immunologic methods for measuring cell membrane and cytoplasmic antigens Cancer 1992 69: (Suppl.) 1543–1552
Riedy MC, Muirhead KA, Jensen CP, Stewart CC . The use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations Cytometry 1991 12: 133–139
Clinical Application of Flow Cytometry: Immunophenotyping of Leukemic Cells; Proposed Guidelines Document H43-P National Committee for Clinical Laboratory Standards: Villanova, PA 1993
Snedecor G, Cochran W . Statistical Methods, 8th edn, Iowa State University Press: Iowa 1989 pp 138–142
Neter J, Wasserman W, Kutner M . Applied Linear StatisticalModels Irwin: Boston 1990 pp 646–647
Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA, Herzig RH, Hong R, Masaoka T, Rimm AA, Ringden O, Speck B, Weiner RS, Bortin MM . T-cell depletion of HLA-identical transplants in leukemia Blood 1991 78: 2120–2130
Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffmann RG, Jacobsen SJ, Marmont AM, McGlave PB, Messner HA, Rimm AA, Rozman C, Speck B, Tura S, Weiner RS . Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion Ann Intern Med 1988 108: 806–814
Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H . Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 1995 86: 2041–2050
Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J . Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 1997 15: 433–444
Acknowledgements
This work was supported partially by Public Health Service Grants CA 16056 and CA 67108 awarded by the National Cancer Institute, US Department of Health and Human Services.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wetzler, M., Baer, M., Stewart, S. et al. HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse. Leukemia 15, 128–133 (2001). https://doi.org/10.1038/sj.leu.2401982
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401982
Keywords
This article is cited by
-
Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression
Cancer Immunology, Immunotherapy (2019)
-
Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy
Leukemia (2015)
-
Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy
Leukemia (2012)
-
Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity
Cancer Immunology, Immunotherapy (2011)
-
In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray
Leukemia (2009)